Literature DB >> 32333888

The transformative potential of plasma phosphorylated tau.

Clifford R Jack1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32333888     DOI： 10.1016/S1474-4422(20)30112-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.

Authors:  Alexis Moscoso; Michel J Grothe; Nicholas J Ashton; Thomas K Karikari; Juan Lantero Rodriguez; Anniina Snellman; Marc Suárez-Calvet; Henrik Zetterberg; Kaj Blennow; Michael Schöll
Journal:  Brain       Date:  2021-02-12       Impact factor: 13.501

Review 2.  Blood-based biomarkers for Alzheimer's disease.

Authors:  Antoine Leuzy; Niklas Mattsson-Carlgren; Sebastian Palmqvist; Shorena Janelidze; Jeffrey L Dage; Oskar Hansson
Journal:  EMBO Mol Med       Date:  2021-12-03       Impact factor: 12.137

Review 3.  Alzheimer's disease - the journey of a healthy brain into organ failure.

Authors:  Todd E Golde
Journal:  Mol Neurodegener       Date:  2022-03-05       Impact factor: 14.195

4.  Association of plasma P-tau181 with memory decline in non-demented adults.

Authors:  Joseph Therriault; Andrea L Benedet; Tharick A Pascoal; Firoza Z Lussier; Cecile Tissot; Thomas K Karikari; Nicholas J Ashton; Mira Chamoun; Gleb Bezgin; Sulantha Mathotaarachchi; Serge Gauthier; Paramita Saha-Chaudhuri; Henrik Zetterberg; Kaj Blennow; Pedro Rosa-Neto
Journal:  Brain Commun       Date:  2021-06-14

5.  Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition.

Authors:  Boris Stephan Rauchmann; Thomas Schneider-Axmann; Robert Perneczky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-06-29       Impact factor: 10.154
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.